$535 Million is the total value of Eagle Health Investments LP's 27 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 166.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ICLR | Buy | ICON PLC | $46,587,240 | +39.9% | 186,200 | +19.4% | 8.71% | +34.4% |
| DHR | New | DANAHER CORPORATION | $41,300,400 | – | 172,085 | +100.0% | 7.72% | – |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $37,712,489 | +28.3% | 170,838 | +30.2% | 7.05% | +23.2% |
| CTLT | New | CATALENT INC | $19,929,167 | – | 459,621 | +100.0% | 3.73% | – |
| TMDX | New | TRANSMEDICS GROUP INC | $19,486,047 | – | 232,032 | +100.0% | 3.64% | – |
| Buy | PROCEPT BIOROBOTICS CORP | $11,920,656 | +47.7% | 337,218 | +18.6% | 2.23% | +41.9% | |
| FUSN | New | FUSION PHARMACEUTICALS INC | $3,177,328 | – | 680,370 | +100.0% | 0.59% | – |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $2,773,647 | – | 306,142 | +100.0% | 0.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
| ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
| NATERA INC | 12 | Q3 2023 | 8.5% |
| ARGENX SE | 12 | Q3 2023 | 7.0% |
| DEXCOM INC | 12 | Q3 2023 | 5.7% |
| OUTSET MED INC | 12 | Q3 2023 | 7.3% |
| AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
| ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-10 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.